%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2019-04-18T11:10:42+05:30
2019-04-18T11:10:45+05:30
2019-04-18T11:10:45+05:30
Adobe InDesign CS6 (Macintosh)
uuid:19983085-e69a-894b-87f1-00db878ca561
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.id:0480117407206811822ADBFD96D573B3
proof:pdf
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2019-04-18T11:10:42+05:30
xmp.iid:FC7F117407206811822AAD25D7419801
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.did:01801174072068118DBB881A9EDFAAFA
default
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
44 0 obj
<>stream
q
/GS0 gs
/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
11 0 0 11 36 42.6404 Tm
(32)Tj
ET
q
0 g
/GS0 gs
/Fm1 Do
Q
q
0 0 612 792 re
W n
BT
/T1_1 1 Tf
13 0 0 13 36 686.808 Tm
(R)Tj
9.1 0 0 9.1 44.6709 686.808 Tm
(EFE)Tj
/Span<>> BDC
(R)Tj
EMC
(ENCES)Tj
ET
Q
BT
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
10 0 0 10 36 661.808 Tm
( )Tj
EMC
[(1)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.047 Tw 1.8 0 Td
[(Han X, Kilfo)45(y B)29.8(, Zheng )49.9(T)99.8(, et al. L)69.8(ymphoma sur)-19.8(vi)24.9(v)24.9(al patter)-19.8(ns )]TJ
0.063 Tw 0 -1.2 TD
[(b)24.9(y )30.2(WHO subtype in the United )0.5(States, 1973\2262003. )]TJ
/T1_3 1 Tf
0 Tw (Cancer )Tj
T*
[(Causes Contr)45(ol)]TJ
/T1_2 1 Tf
( 2008 Oct;19\(8\):841\22658.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(2)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.085 Tw 1.8 0 Td
[(He XL, )89.6(Y)110.8(u F)129.8(, Guo )49.5(T)99.9(, et al. )49.5(T)139.9(-cell l)24.9(ymphob)19.8(lastic l)24.9(ymphoma )]TJ
0.039 Tw T*
[(presenting with pleural ef)25(fusion: )54.5(A case repor)-19.7(t. )]TJ
/T1_3 1 Tf
(Respir Med )Tj
0 Tw T*
(Case Rep.)Tj
/T1_2 1 Tf
[( 2014 Ma)35(y 4;12:55\2268.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(3)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.173 Tw 1.8 0 Td
[(Dores GM, De)24.9(v)14.9(esa SS, Cur)-19.7(tis RE, et al. )54.6(Acute leuk)9.8(emia )]TJ
0.176 Tw T*
[(incidence )0.6(and )0.5(patient )0.6(sur)-19.8(vi)24.9(v)24.9(al )0.6(among )0.5(children )0.6(and )0.5(adults )]TJ
0.056 Tw T*
(in the United States, 2001\2262007. )Tj
/T1_3 1 Tf
0 Tw (Blood)Tj
/T1_2 1 Tf
0.056 Tw ( 2012 Jan 5;119\(1\):)Tj
0 Tw ( )Tj
T*
(34\22643.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(4)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.029 Tw 1.8 0 Td
[(Muthusam)39.8(y P)159.9(, Ebrom S, Cohle SD)59.9(, et al. P)39.7(ericardial )0.5(in)39.7(v)19.8(olv)14.9(e)]TJ
0 Tw (-)Tj
0.07 Tw T*
[(ment as an initial presentation of anaplastic lar)17.8(ge cell l)24.9(ym)]TJ
0 Tw (-)Tj
T*
(phoma. )Tj
/T1_3 1 Tf
[(Can F)75(am Ph)19.8(ysician)]TJ
/T1_2 1 Tf
( 2014 Jul;60\(7\):638\22641.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(5)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.18 Tw 1.8 0 Td
[(El Sa)34.9(y)19.8(ed MJ)59.8(, Gharzuddin )30.1(W)149.9(, Kharf)-9.7(an-Dabaja MA. )50(T)139.9(-cell )]TJ
0.464 Tw T*
[(acute l)24.9(ymphob)19.8(lastic leuk)9.8(emia presenting )0.5(as a cardiac )]TJ
0 Tw T*
(tamponade. )Tj
/T1_3 1 Tf
0.189 Tw 5.077 0 Td
[(A)19.8(ustin J Emer)24.9(g)9.8(ency & Crit Car)36.8(e Med)]TJ
/T1_2 1 Tf
( 2014;)Tj
0 Tw ( )Tj
-5.077 -1.2 Td
(1\(2\):4.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
26.4 21.935 Td
( )Tj
EMC
[(6)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.161 Tw 1.8 0 Td
[(Mar)-19.8(tin SE, Zhang HZ, Magyarosy E, et al. Immunolo)24.9(gic )]TJ
0.055 Tw T*
[(methods in c)14.9(ytolo)24.9(gy: de\037niti)24.9(v)14.9(e diagnosis of non-Hodgkin\222)139.9(s )]TJ
0.068 Tw T*
[(l)24.9(ymphomas using immunolo)25(gic mark)9.8(ers for )50.2(T)139.9(- and B-cells. )]TJ
/T1_3 1 Tf
0 Tw T*
[(Am J Clin P)79.9(athol)]TJ
/T1_2 1 Tf
( 1984 Dec;82\(6\):666\22673.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(7)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.075 Tw 1.8 0 Td
[(McDonnell )0.5(PJ)59.8(, )0.5(Mann )0.5(RB)29.8(, )0.5(Bulkle)14.9(y )0.5(BH. )0.5(In)39.8(v)19.8(olv)14.9(ement )0.5(of )0.5(the )]TJ
0.213 Tw T*
[(hear)-19.7(t b)24.9(y malignant l)24.9(ymphoma: a clinicopatholo)25(gic study)85(. )]TJ
/T1_3 1 Tf
0 Tw T*
(Cancer)Tj
/T1_2 1 Tf
( 1982 Mar 1;49\(5\):944\22651.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(8)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.011 Tw 1.8 0 Td
[(P)39.8(etersen CD)59.8(, Robinson )29.4(W)119.9(A, K)25(ur)-19.8(nick JE. In)39.8(v)19.8(olv)14.9(ement of the )]TJ
0.13 Tw T*
[(hear)-19.7(t and )0.5(pericardium )0.5(in )0.5(the )0.5(malignant )0.5(l)24.9(ymphomas. )]TJ
/T1_3 1 Tf
[(Am )0.5(J )]TJ
0 Tw T*
(Med Sci.)Tj
/T1_2 1 Tf
( 1976 Sep-Oct;272\(2\):161\2265.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(9)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.192 Tw 1.8 0 Td
[(Cha)34.9(v)14.9(es FP)159.9(, Quillen K, Xu D)59.8(. P)39.8(ericardial ef)24.9(fusion: a rare )]TJ
0.13 Tw T*
[(presentation of adult t-cell leuk)9.8(emia/l)24.9(ymphoma. )]TJ
/T1_3 1 Tf
0 Tw (American )Tj
T*
[(J)24.9(ournal of Hematolo)25(g)-19.8(y)]TJ
/T1_2 1 Tf
( 77:381\226383 \(2004\).)Tj
/T1_0 1 Tf
-1.8 -1.2 Td
(10.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
-0.095 Tw 0.58 0 Td
[(Imazio M, Demichelis B)29.7(, P)14.8(ar)-29.7(rini I, et al. Relation of acute per)]TJ
0 Tw 23.667 0 Td
(-)Tj
-23.667 -1.2 Td
[(icardial disease to malignanc)15(y)85(. )]TJ
/T1_3 1 Tf
[(Am J Car)36.9(diol)]TJ
/T1_2 1 Tf
( 2005;95:1393.)Tj
/T1_0 1 Tf
-1.8 -1.2 Td
(11.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.083 Tw 0.58 0 Td
[(Ak)9.8(o J)59.9(, Eto M, Kim S, et al. P)39.8(ericardial constriction due to )]TJ
0 Tw T*
[(malignant l)24.9(ymphoma. )]TJ
/T1_3 1 Tf
(Jpn Heart J)Tj
/T1_2 1 Tf
( 2000;41:673\226679.)Tj
/T1_0 1 Tf
-1.8 -1.2 Td
(12.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
-0.057 Tw 0.58 0 Td
[(Monappa )49.5(V)199.9(, Reddy S, K)24.9(udv)24.9(a R. Hematol)24.9(ymphoid neoplasms )]TJ
0 Tw T*
[(in ef)24.9(fusion c)14.9(ytolo)25(gy)84.9(. )]TJ
/T1_3 1 Tf
(Cytojournal)Tj
/T1_2 1 Tf
( 2018;15:15.)Tj
ET
endstream
endobj
24 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 271.853 45.1778 Tm
(The Southwest Respiratory and Critical Care Chronicles 2019;7\(28\):28\226\
32)Tj
ET
endstream
endobj
37 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.5 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 36 59.8957 cm
0 0 m
540 0 l
S
Q
10 M
q 1 0 0 1 36 731.2762 cm
0 0 m
540 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 36 742.5262 Tm
(Rao et al.)Tj
/Span<>> BDC
( )Tj
EMC
21.995 0 Td
[(Pericardial Effusion and Constriction as an Initial Presentation of )34.3(Acute t-cell L)17.8(ymphoblastic L)17.2(ymphoma)]TJ
ET
endstream
endobj
48 0 obj
<>
endobj
49 0 obj
<>
endobj
50 0 obj
<>stream
H\n0yCi%4Vhb:P~6:i ı(o'V8.߂E}k&Ѯ}mW*"j'J*tAq
~zvW*zC髨V:nI:ϵÆkݡuN|N|dYoDCm1*i:;zϞ:,qLQ|>6D2)A\ĩO9~' 1cò/Nx,w {=h XH^yPucX=cX=&.\zz!W{Z<
ɋ?+ k
endstream
endobj
51 0 obj
<>stream
HlUX~W;*d*rO iĜN.QRƸ`$aaA*w9-5.O7soh%`|wkk{<'L
Ox @ހtU\ (Y}bR#m:,FG8=ßDV^wMJ9l_?=g_W$(6<%A ށ|^~ߒ14!>1Is2MjO:_o(*ǶU 'jW)lLUaSfBJ3Ń#kƉėko5mP1;Fȑ|h>7LLZleaiemckM[{v;8u;:uvq=wnݽzxۧO~;oaG0r1A7Ð ?[&M25Ӧψ9kvLl\|I秤.x'/Y,mOWZٚ2o_|eWY۲ؙ_쑅ݷ@qIC=vDΗ_˸rykjtsA4)6₨NzU:]
3X
'!0RTTW`?hjsVoo7'?34@&iK`de-M݊MuYΪM\SfPT3fJM;
VejYsߩ髷@
D.ca3Sd`
a7`i؈_+wƟoЀ rPr÷T qQQ+؋(hG,l"qxA"dC`R1>BN,j.RVBƥ
^[G0qGd5c㪎Aـ[Ay2*q[5`$1X.ôZ83ͩ\\T:!